Connect with us
Novartis is aiming for its annual sales to grow in the high single digits this year when it previously estimated they would grow in the mid-single...
Novartis has stated that it is focused on five therapeutic areas, including cardiovascular, immunology, and neuroscience. By markets, the company has detailed that it plans to...
Thanks to this investment plan, Novartis Italia, which already achieved a turnover of €1.72 billion in 2022, €78 million of which was obtained through exports, further...
This year, one of the main headaches for managers in the sector will be inflation. GSK and Novartis plan to carry out a double-digit price increase...
Novartis has the worst rating in the European pharmaceutical industry, while AstraZeneca downgrades its expectations from exceptional to neutral. Credit Suisse has also analyzed the Spanish...
The Swiss pharmaceutical company plans to lay off 8,000 workers worldwide, equivalent to 7.7% of the total workforce. The Novartis job cuts are part of the...
Spinal muscular atrophy is a rare disease caused by an alteration in the SMN1 gene which leads to progressive muscle weakness, as the lack of SMN...
A compassionate use program that included 12 ARDS patients associated with COVID-19 was launched in March. The patients were in mechanical ventilation. The therapy was associated...
The global slowdown in economic growth has so far left Roche and Novartis' businesses untouched. Both drug manufacturers, based in Basel, are currently growing significantly faster...
Parents of children with serious health conditions are facing high costs of healthcare.